Known as Breast Circulating Methylation Assay (BCMA), the new blood test looks for tumour DNA released into the bloodstream ...

PITTSBURGH - Researchers at the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh discovered a promising ...

Researchers at the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh discovered a promising new biomarker of ...

Study highlights epigenetic changes of the BDNF gene after TBI and offers new insights into recovery and precision ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present a total of 14 abstracts with its ...

CLEVELAND and DURHAM, N.C., Nov. 11, 2025 /PRNewswire/ -- GenomOncology today announced a strategic partnership with the Glioblastoma Foundation to transform genomic testing for the nation's most ...

Abstract: Lung cancer is the third most common cause of cancer death worldwide. Lung adenocarcinoma (LUAD), its predominant subtype, is particularly lethal due to the delayed diagnosis, variability, ...

ABSTRACT: Glioblastoma multiforme (GBM) is the most aggressive and lethal primary brain tumor in adults with limited treatment options and a median survival of 12 - 15 months. In recent years, ...

CHICAGO, July 7, 2025 /PRNewswire/ -- Belay Diagnostics, a CLIA/CAP accredited laboratory focused on the development and commercialization of molecular diagnostics targeting central nervous system ...